Mark Mahaney, Evercore ISI head of internet research, joins 'Squawk Box' to discuss news of Netflix shares hitting all-time ...

The stock market (SP500), (DJI), (COMP:IND) is due for a pause following a “massive blowout” earnings rally in May, according ...

June could provide an opportunity for investors according to Evercore ISI with the Fed expected to lower interest rates and ...

Evercore ISI, an independent investment banking advisory and research firm, highlights a significant shift in the insurance ...

On Thursday, Evercore ISI analysts lowered the price target for Brown Forman (NYSE:BFb) (NYSE:BF-B) stock to $30 from $38, maintaining an In Line rating. The decision comes after the company’s ...

With the S&P 500 Index setting record after record, Evercore ISI is predicting another double-digit rally through the end of 2024. Julian Emanuel, the firm’s chief equity and quantitative ...

Evercore ISI analysts pointed out that Apple Inc. (NASDAQ:AAPL) is likely to introduce its foundation models to app ...

NEW YORK (Reuters) - Evercore ISI on Wednesday forecast the S&P 500 will rise to 6,600 by mid-2025, saying a "decisive and uncontested" win by Donald Trump as U.S. president and a potential ...

Evercore ISI also resumed coverage of Viper Energy with an Outperform rating, emphasizing the company’s ability to maintain its 2025 volume guidance amid reduced activity from its parent company.

Evercore ISI reduced its price target for HP Inc (NYSE:HPQ) from $32 to $29 on May 29, 2025, but maintained an Outperform ...

Evercore ISI analyst Liisa Bayko upgraded Editas Medicine (EDIT) to Outperform from In Line with a price target of $7, up from $3. Editas has $322M in cash including the recent DRI royalty deal ...

Evercore ISI analyst Gavin Clark-Gartner initiated coverage with a Buy rating on Mirum Pharmaceuticals (MIRM – Research Report) today and set a price target of $68.00. The company’s shares ...